HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

erucylphospho- N,N,N- trimethylpropylammonium

an antineoplastic agent
Also Known As:
ErPC3 cpd; erufosine
Networked: 16 relevant articles (6 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Berger, Martin R: 7 articles (03/2014 - 08/2002)
2. Jendrossek, Verena: 4 articles (05/2014 - 01/2009)
3. Zaharieva, Maya M: 4 articles (01/2014 - 06/2007)
4. Konstantinov, Spiro M: 4 articles (11/2012 - 08/2002)
5. Eibl, Hansjörg: 3 articles (11/2012 - 08/2002)
6. Lindner, Lars H: 3 articles (01/2012 - 07/2008)
7. Belka, Claus: 3 articles (01/2012 - 01/2009)
8. Dineva, Ilina K: 2 articles (11/2012 - 06/2007)
9. Henke, Guido: 2 articles (01/2012 - 01/2009)
10. Bamberg, Michael: 2 articles (01/2012 - 01/2009)

Related Diseases

1. Neoplasms (Cancer)
2. Glioblastoma (Glioblastoma Multiforme)
3. Carcinoma (Carcinomatosis)
4. BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
5. Body Weight (Weight, Body)

Related Drugs and Biologics

1. Retinoblastoma Protein
2. Methylnitrosourea (N-Methyl-N-nitrosourea)
3. erucylphospho- N,N,N- trimethylpropylammonium
4. 2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- one
5. Paxillin
6. Small Interfering RNA (siRNA)
7. Sirolimus (Rapamycin)
8. Extracellular Matrix Proteins
9. Integrins
10. Proteins (Proteins, Gene)

Related Therapies and Procedures

1. Radiotherapy
2. Heterologous Transplantation (Xenotransplantation)
3. Injections
4. Subcutaneous Injections